<?xml version="1.0" encoding="UTF-8"?>
<html xmlns="http://www.w3.org/1999/xhtml">
 <head charset="UTF-8"/>
 <style> * { font-family : helvetica;} .font16 { font-size : 16; } .font18 { font-size : 18; } .font19 { font-size : 19; } .font21 { font-size : 21; } .font22 { font-size : 22; } .font10 { font-size : 10; } .font11 { font-size : 11; } .font12 { font-size : 12; } .font13 { font-size : 13; } .font30 { font-size : 30; } .font14 { font-size : 14; } .font15 { font-size : 15; }</style>
 <body>
  <p>
   <span class="font30">(.) </span>
   <span class="font22">(.–.) </span>
   <span class="font21">HIV </span>
   <span class="font19">STI </span>
   <span class="font18">N =  </span>
   <span class="font16">adolescents </span>
   <span class="font16">young </span>
   <span class="font15">testing </span>
   <span class="font14">adults </span>
   <span class="font14">risk </span>
   <span class="font14">sexual </span>
   <span class="font14">data </span>
   <span class="font14">screening </span>
   <span class="font13">Xpert </span>
   <span class="font13">treatment </span>
   <span class="font13">(.–.; </span>
   <span class="font13">{border-style </span>
   <span class="font13">:–. </span>
   <span class="font13">STIs </span>
   <span class="font13">patients </span>
   <span class="font13">prevalence </span>
   <span class="font13">px;} </span>
   <span class="font13">sexually </span>
   <span class="font13">syndromic </span>
   <span class="font13">#ffffff;} </span>
   <span class="font12">infections </span>
   <span class="font12">women </span>
   <span class="font12">CT, </span>
   <span class="font12">NG, </span>
   <span class="font12">Reference </span>
   <span class="font12">[]. </span>
   <span class="font12">transmitted </span>
   <span class="font12">Eswatini </span>
   <span class="font12">study </span>
   <span class="font12">using </span>
   <span class="font12">Health </span>
   <span class="font12">South </span>
   <span class="font12">population </span>
   <span class="font12">Sexually </span>
   <span class="font12">age </span>
   <span class="font12">care </span>
   <span class="font12">involved </span>
   <span class="font12">participants </span>
   <span class="font12">people </span>
   <span class="font12">positive </span>
   <span class="font11">enrolled </span>
   <span class="font11">vaginal </span>
   <span class="font11">years </span>
   <span class="font11">(.%) </span>
   <span class="font11">Age </span>
   <span class="font11">CT/NG </span>
   <span class="font11">Sexual </span>
   <span class="font11">associated </span>
   <span class="font11">comprehensive </span>
   <span class="font11">high </span>
   <span class="font11">identified </span>
   <span class="font11">need </span>
   <span class="font11">reported </span>
   <span class="font11">transmission </span>
   <span class="font11">urine </span>
   <span class="font11">(OR = .; </span>
   <span class="font11">(–) </span>
   <span class="font11">Baylor </span>
   <span class="font11">CI, </span>
   <span class="font11">Infect </span>
   <span class="font11">cohort </span>
   <span class="font11">detection </span>
   <span class="font11">infection </span>
   <span class="font11">new </span>
   <span class="font11">project </span>
   <span class="font11">provided </span>
   <span class="font11">px; </span>
   <span class="font11">{font-family </span>
   <span class="font11">Current </span>
   <span class="font11">HIV. </span>
   <span class="font11">Neisseria </span>
   <span class="font11">Yes </span>
   <span class="font11">cases </span>
   <span class="font11">clinic </span>
   <span class="font11">factors </span>
   <span class="font11">font-size </span>
   <span class="font11">gonorrhea </span>
   <span class="font11">health </span>
   <span class="font11">living </span>
   <span class="font11">rates </span>
   <span class="font11">specimen </span>
   <span class="font11">test </span>
   <span class="font11">(%) </span>
   <span class="font11">(Table </span>
   <span class="font11">Active </span>
   <span class="font11">Children’s </span>
   <span class="font11">Chlamydia </span>
   <span class="font11">Dis; </span>
   <span class="font11">ESAP </span>
   <span class="font11">Female </span>
   <span class="font11">HIV, </span>
   <span class="font11">Male </span>
   <span class="font11">STI, </span>
   <span class="font11">Trichomonas </span>
   <span class="font11">bivariate </span>
   <span class="font11">clinical </span>
   <span class="font11">condom </span>
   <span class="font11">diagnostic </span>
   <span class="font11">double; </span>
   <span class="font11">high-burden </span>
   <span class="font11">immunodeficiency </span>
   <span class="font11">indicating </span>
   <span class="font11">million </span>
   <span class="font11">needed </span>
   <span class="font11">negative </span>
   <span class="font11">older </span>
   <span class="font11">partner </span>
   <span class="font11">predictive </span>
   <span class="font11">results </span>
   <span class="font11">sensitivity </span>
   <span class="font11">trachomatis </span>
   <span class="font11">viral </span>
   <span class="font10">:e. </span>
   <span class="font10">Africa </span>
   <span class="font10">Africa. </span>
   <span class="font10">Africa: </span>
   <span class="font10">CI) </span>
   <span class="font10">College </span>
   <span class="font10">GeneXpert </span>
   <span class="font10">HIV-infected </span>
   <span class="font10">Mbabane, </span>
   <span class="font10">Ministry </span>
   <span class="font10">STIs, </span>
   <span class="font10">Sex </span>
   <span class="font10">TV, </span>
   <span class="font10">active </span>
   <span class="font10">analysis. </span>
   <span class="font10">border-color </span>
   <span class="font10">border-width </span>
   <span class="font10">confidence </span>
   <span class="font10">diagnosis </span>
   <span class="font10">genital </span>
   <span class="font10">human </span>
   <span class="font10">lower </span>
   <span class="font10">majority </span>
   <span class="font10">management </span>
   <span class="font10">months </span>
   <span class="font10">oropharyngeal </span>
   <span class="font10">performance </span>
   <span class="font10">populations </span>
   <span class="font10">prevention </span>
   <span class="font10">prior </span>
   <span class="font10">repeat </span>
   <span class="font10">reporting </span>
   <span class="font10">solid; </span>
   <span class="font10">support </span>
   <span class="font10">testing, </span>
   <span class="font10">treated </span>
   <span class="font10">use </span>
   <span class="font10">{font-style </span>
   <span class="font10">{font-weight </span>
   <span class="font10">(.–) </span>
   <span class="font10">(IQR, </span>
   <span class="font10">(male, </span>
   <span class="font10">(–), </span>
   <span class="font10">.%) </span>
   <span class="font10">.%; </span>
   <span class="font10">.–.) </span>
   <span class="font10">Abbreviations: </span>
   <span class="font10">CI, .–.), </span>
   <span class="font10">Disease </span>
   <span class="font10">Months, </span>
   <span class="font10">NPV </span>
   <span class="font10">PPV </span>
   <span class="font10">Risk </span>
   <span class="font10">Sensitivity </span>
   <span class="font10">Specificity </span>
   <span class="font10">Syndromic </span>
   <span class="font10">Table </span>
   <span class="font10">Transm </span>
   <span class="font10">World </span>
   <span class="font10">additional </span>
   <span class="font10">adverse </span>
   <span class="font10">and/or </span>
   <span class="font10">asymptomatic </span>
   <span class="font10">bold </span>
   <span class="font10">courier; </span>
   <span class="font10">cross-sectional </span>
   <span class="font10">current </span>
   <span class="font10">effective </span>
   <span class="font10">em; </span>
   <span class="font10">female, </span>
   <span class="font10">females </span>
   <span class="font10">higher </span>
   <span class="font10">included </span>
   <span class="font10">increased </span>
   <span class="font10">inflammation </span>
   <span class="font10">median </span>
   <span class="font10">national </span>
   <span class="font10">outcomes </span>
   <span class="font10">performed </span>
   <span class="font10">potential </span>
   <span class="font10">pt;} </span>
   <span class="font10">retested </span>
   <span class="font10">risk. </span>
   <span class="font10">settings </span>
   <span class="font10">suggest </span>
   <span class="font10">support. </span>
   <span class="font10">surveillance </span>
   <span class="font10">swabs </span>
   <span class="font10">tested </span>
   <span class="font10">testing. </span>
   <span class="font10">total </span>
   <span class="font10">used </span>
   <span class="font10">vaginalis </span>
  </p>
 </body>
</html>
